Paulus H
Behring Inst Mitt. 1985 Dec(78):118-32.
Bispecific antibodies are immunoglobulin molecules with two different antigen binding sites. They can be prepared either by chemical crosslinking of immunoglobulins with different antigen specificities or by reassortment of the polypeptide chains from two different immunoglobulins to produce hybrid molecules with dual specificity. None of the earlier methods for the preparation of bispecific antibodies assure molecular homogeneity without difficult purification procedures; recently, however, a facile and efficient method was developed which can yield pure bispecific antibodies from monoclonal antibody fragments. This new method avoids some of the problems encountered earlier by using arsenite as a dithiol complexing agent to prevent intramolecular disulfide formation and 5,5'-dithiobis (2-nitrobenzoic acid) as a thiol activating agent to effect the directed recombination of two different antibody half-molecules. Bispecific monoclonal antibodies thus obtained are useful heterobifunctional reagents on account of their ability to bind two different antigens in a uniquely defined spatial relationship. They have potential applications as agents for enzyme immobilization, in the assembly of enzyme electrodes and multienzyme complexes, as reagents for two-site and homogeneous immunoassays, as electron microscopy markers for subcellular structures, and as targeting agents for cytotoxic drugs. In many of these applications, bispecific monoclonal antibodies have fundamental advantages over the heterogeneous mixtures containing hybrid antibodies that were available in the past.
双特异性抗体是具有两个不同抗原结合位点的免疫球蛋白分子。它们可以通过将具有不同抗原特异性的免疫球蛋白进行化学交联,或者通过重排来自两种不同免疫球蛋白的多肽链以产生具有双重特异性的杂交分子来制备。早期制备双特异性抗体的方法,如果不经过繁琐的纯化程序,都无法保证分子的同质性;然而,最近开发了一种简便高效的方法,该方法可以从单克隆抗体片段中产生纯的双特异性抗体。这种新方法通过使用亚砷酸盐作为二硫醇络合剂来防止分子内二硫键形成,并使用5,5'-二硫代双(2-硝基苯甲酸)作为硫醇活化剂来实现两种不同抗体半分子的定向重组,从而避免了早期遇到的一些问题。如此获得的双特异性单克隆抗体因其能够以独特定义的空间关系结合两种不同抗原而成为有用的异双功能试剂。它们在酶固定化、酶电极和多酶复合物的组装、双位点和均相免疫测定的试剂、亚细胞结构的电子显微镜标记以及细胞毒性药物的靶向剂等方面具有潜在应用。在许多这些应用中,双特异性单克隆抗体相对于过去可用的含有杂交抗体的异质混合物具有根本优势。